Johnson & Johnson Details Launch Plans Regarding Kenvue IPO Roadshow
Pharmaceutical powerhouse J&J expects to price its Kenvue IPO shares at $20 to $23 for a potential $40 billion company valuation. Johnson & Johnson (NYSE: JNJ) plans to price shares of its upcoming Kenvue Inc IPO between $20 and $23. The initial public offering roadshow constitutes more than $151 million shares of common stock
Read More